TAMARA A. FAVORITO - 01 Jul 2022 Form 4 Insider Report for Kintara Therapeutics, Inc. (KTRA)

Role
Director
Signature
/s/ Anthony Scott Praill, attorney-in-fact for Tamara A. Seymour
Issuer symbol
KTRA
Transactions as of
01 Jul 2022
Transactions value $
$0
Form type
4
Filing time
05 Jul 2022, 16:05:43 UTC
Previous filing
30 Jun 2022
Next filing
21 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KTRA Options (Right to Buy) Award $0 +100K $0.00 100K 01 Jul 2022 Common Stock 100K $0.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on August 1, 2022.